Cancergenetik i Stockholm AB

ABActive

Org 5569896821Skogsvägen 3, 181 41 LidingöGeneral medical practice activities · NACE 8621Est. 20141 employees

Overview Financials People & ownership Related companies

Cancergenetik i Stockholm AB is a Swedish AB based in Lidingö, operating in the Primärvårdsmottagningar med läkare m.m. sector. Incorporated in 2014, the company has 1 employee and reported revenue of SEK 250K in its latest annual filing.

Revenue 2025

SEK 250K

EBITDA margin

56.4%

+147% vs 2024

Equity ratio

96.9%

Financial strength

Net profit 2025

SEK 146K

+196% vs 2024

EBITDA — year on year

SEK millions

Key figures

Annual report 2025

Revenue	SEK 250K	—
EBITDA	SEK 141K	+147%
Net profit	SEK 146K	+196%
Total assets	SEK 516K	-7%
Equity	SEK 500K	+39%
Employees	1	—

Contact

Address

Skogsvägen 3, 181 41 Lidingö

annika.lindblom@ki.se

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Cancergenetik i Stockholm AB?

Cancergenetik i Stockholm AB is registered with Bolagsverket / SCB under Org 5569896821.

What is the revenue of Cancergenetik i Stockholm AB?

Cancergenetik i Stockholm AB reported revenue of SEK 250K in 2025.

How many employees does Cancergenetik i Stockholm AB have?

Cancergenetik i Stockholm AB employs 1 people as of the latest annual report.

Who is the chairman of Cancergenetik i Stockholm AB?

Annika Elisabet Lindblom chairs the board of Cancergenetik i Stockholm AB, in role since 2022.

Where is Cancergenetik i Stockholm AB headquartered?

Cancergenetik i Stockholm AB's registered address is Skogsvägen 3.

Cancergenetik i Stockholm AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Cancergenetik i Stockholm AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Cancergenetik i Stockholm AB